Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy

NCT01560624 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

690

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: Treprostinil Diolamine
DRUG: Placebo

Sponsor

United Therapeutics